Thomas Steyer’s Affimed AFMD Stock Holding History

Thomas Steyer’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,000	Closed	-$3.96M	–	300
2021 Q1	$3.96M	Buy	+50,000	New	+$3.25M	0.02%	202

Other funds holding AFMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thomas Steyer's AFMD Position: Q2 2021 in Review

Thomas Steyer sold out of Affimed (AFMD) in Q2 2021, closing a stake of 50,000 shares — an estimated $3.96M sold.

Thomas Steyer first reported a position in AFMD in Q1 2021 and held it in 1 quarter. The position peaked at $3.96M in Q1 2021. 146 funds tracked by Wall St. Rank hold AFMD as of Q2 2021.

Thomas Steyer reported no remaining Affimed position as of Q2 2021 after selling out during the quarter.
Thomas Steyer sold 50,000 Affimed shares in Q2 2021, an estimated $3.96M.
Thomas Steyer first reported a position in Affimed in Q1 2021 and held it in 1 quarter.
Thomas Steyer's Affimed position peaked at $3.96M in Q1 2021.
146 funds tracked by Wall St. Rank held Affimed as of Q2 2021.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.